Skip to search formSkip to main contentSkip to account menu

HYB-2055

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Oligonucleotides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Technology evaluation: HYB-2055, Hybridon.
  • T. ŚwitajW. Lasek
  • Current opinion in molecular therapeutics (Print)
  • 2005
  • Corpus ID: 44623347
Hybridon is developing immunomodulatory oligonucleotides. including injectable HYB-2055 (IMOxine) which acts as an agonist of… 
2005
2005
Gateways to clinical trials.
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)